IndustryCompany release

Merck KGaA to acquire Rapid Micro Biosystems; Q3 revenue rises to $9.5M

🇺🇸 Rapid Micro Biosystems, Inc. (RPID) · Mon 16 Nov 2026

Rapid Micro Biosystems, maker of the Growth Direct microbial QC system, reported record gross margin and agreed a tender-offer deal with Merck KGaA, Darmstadt, while withdrawing 2026 guidance.

Rapid Micro Biosystems has announced a definitive agreement to be acquired by Merck KGaA, Darmstadt. The deal is to be carried out through a tender offer, which has not yet begun, according to the company's announcement of 16 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Company's press release (SEC filing): Rapid Micro Biosystems, Inc. ↗

Article written by VigiEye from the official source (Rapid Micro Biosystems, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →